Picture of DarioHealth logo

DRIO — DarioHealth News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

DarioHealth Corp expected to post a loss of 54 cents a share - Earnings Preview

* DarioHealth Corp  DRIO.OQ   DRIO.O  is expected to show a
fall
in quarterly revenue when it reports  results on March 28 for
the period ending December 31 2023
    * The New York City-based  company is expected to report a
47.5% decrease in revenue to $3.572 million from $6.81 million a
year ago, according to the mean estimate from 2 analysts, based
on LSEG data.
    * ​LSEG's mean analyst estimate for DarioHealth Corp is for
a loss
of 54 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for DarioHealth
Corp
is $5.25​, above​ its last closing price of $1.49. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.48       -0.46      -0.49     Missed  -6.5
 Jun. 30 2023  -0.57       -0.52      -0.58     Missed  -11.1
 Mar. 31 2023  -0.49       -0.50      -0.45     Beat    9.6​
 Dec. 31 2022  -0.56       -0.65      -0.51     Beat    21.8
 ​​Sep.        -0.71       -0.76      -0.64     Beat    16.1
 30 2022                                                
 Jun. 30 2022  -0.71       -0.71      -0.74     Missed  -3.9​
 Mar. 31 2022  -0.96       -0.96      -0.74     Beat    22.7
 Dec. 31 2021  -1.09       -1.06      -1.09     Missed  -3.2
 This summary was machine generated March 26 at 12:46 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on DarioHealth

See all news